April 9, 2026

Sports Vision Training — The $500 Million Market That Pro Teams Are Betting On

Stephen Curry uses strobe goggles. MLB teams evaluate prospects' eye tracking before the draft. The NFL mandates vision tests. What was once fringe sports science is becoming a half-billion dollar market — and the trickle-down to everyday athletes is just starting.


In 2016, Sports Illustrated published a feature on Stephen Curry's training regimen that briefly fascinated the sports world and then, like most training-secret stories, faded into the content cycle. The detail that stuck was the strobe goggles — Eclipse sensory performance glasses that intermittently block vision, forcing the brain to process visual information faster with less data. Curry trained with them alongside FitLight reaction panels, creating a cognitive-visual workout that his trainers credited with sharpening the decision-making speed that makes him the greatest shooter in basketball history.

What the sports world treated as a curiosity, the vision science community recognized as a proof of concept. If the most efficient offensive player in NBA history was investing serious training time in visual performance, the question was not whether sports vision training worked. It was how quickly the rest of the industry would follow.

The answer: quickly, and with real money behind it.

The Market Takes Shape

The global sports vision training market was valued at approximately $500 million in 2024, according to FutureDataStats, with projections reaching $1.1 billion by 2032 at a 10 percent compound annual growth rate. Within the broader $135 billion sports technology market, vision training occupies a small but rapidly growing niche that sits at the intersection of performance optimization, injury prevention, and competitive advantage.

The growth is driven from the top down. Professional leagues have moved from experimenting with vision training to institutionalizing it.

The NFL and NBA now mandate vision tests for all players. These assessments go beyond simple acuity — they evaluate contrast sensitivity, depth perception, peripheral awareness, reaction time, and eye tracking speed. The data feeds scouting reports, injury recovery protocols, and individualized training programs. The Jacksonville Jaguars, among other NFL teams, have partnered with specialized eye care providers who use NeuroTracker and other cognitive-visual platforms as part of standard player development.

Major League Baseball has arguably gone furthest. Multiple organizations now incorporate vision assessment data into draft decisions. The logic is compelling: hitting a 95-mph fastball requires the batter to pick up spin, location, and speed cues within the first 100 milliseconds of the pitch's flight. Visual processing speed is not just helpful — it is a prerequisite skill that can be measured, benchmarked, and trained. RightEye, an eye-tracking assessment platform, has formal partnerships with MLB and USA Baseball. Vizual Edge provides computerized vision training specifically designed for baseball, used by collegiate and professional programs. One college baseball team that adopted a comprehensive vision training program saw conference-leading improvement in hitting metrics within a single season.

NHL teams have integrated Senaptec training stations — which measure ten sensory and motor skills through a standardized evaluation — into their facilities. The technology originally developed for sports has also been adopted by military special forces and law enforcement, reflecting the universal value of visual-cognitive performance.

The Technology Ecosystem

The sports vision training market is not a single product. It is an ecosystem of overlapping technologies, each targeting different aspects of visual-cognitive performance.

Senaptec has built perhaps the most comprehensive platform. Their Sensory Evaluation system measures ten distinct visual-cognitive skills — visual clarity, contrast sensitivity, depth perception, near-far quickness, perception span, multiple object tracking, reaction time, target capture, eye-hand coordination, and go/no-go decision making. The Senaptec Strobe goggles use liquid crystal technology to systematically restrict visual information during training, forcing the brain to process more efficiently with less input.

RightEye approaches the market through eye-tracking technology. Their platform can distinguish between normal and abnormal eye movement patterns with clinical precision, creating both a diagnostic tool (used in concussion assessment and developmental screening) and a training platform (used in sports performance). The MLB partnership gives them access to perhaps the richest dataset on elite athlete visual performance ever compiled.

NeuroTracker takes a cognitive-first approach. Based on more than 20 years of research at the University of Montreal, the system uses 3D multiple object tracking to train sustained attention, processing speed, and situational awareness. Peer-reviewed studies have shown transfer effects from NeuroTracker training to on-field performance metrics, though the research community continues to debate the magnitude and consistency of these effects.

Dynavision's D2 light board is the old-school workhorse of the field — a multi-sensory interactive device that combines visual, motor, and cognitive demands in a physical training format. It lacks the data analytics sophistication of newer platforms but remains widely used in rehabilitation and athletic training facilities.

FitLight — the wireless LED reaction system Curry made famous — focuses specifically on reaction time and cognitive processing speed through light-based stimulus-response drills. Its portability and intuitive design have made it a popular choice for both elite and recreational training settings.

VR Is Raising the Stakes

The most significant technology trend in sports vision training is the integration of virtual reality, and the early evidence is striking.

A systematic review of VR-assisted training for perceptual-cognitive skills in athletes found that VR outperformed traditional video screen-based training, particularly for young athletes. The immersive environment creates training scenarios that more closely replicate the visual demands of actual competition — tracking multiple moving objects in three-dimensional space, making rapid decisions under time pressure, processing peripheral visual information while maintaining central focus.

Adaptive VR training programs have shown evidence for both near transfer (improved performance on VR tasks) and far transfer (improved performance in real-world athletic tasks). In batting practice studies, players trained with VR-based pitch recognition showed measurable improvement in plate discipline and contact rates compared to control groups.

The VR segment of sports vision training is growing faster than the market overall, benefiting from declining hardware costs, improving software sophistication, and the general normalization of VR as a training tool across industries from surgery to aviation.

What Sports Vision Training Is — and What It Is Not

A point of clarification matters here, because the terminology can blur important distinctions.

Sports vision training and clinical vision therapy share underlying principles — both leverage neuroplasticity to improve visual processing — but they serve different populations with different goals. Clinical vision therapy treats diagnosed disorders: convergence insufficiency, amblyopia, post-TBI visual dysfunction. It is medical treatment, typically supervised by a developmental or neuro-optometrist, with outcomes measured against clinical norms.

Sports vision training enhances already-normal visual function. The athlete does not have a disorder — they have a baseline level of visual-cognitive performance that they want to improve. The training is performance optimization, closer in concept to strength and conditioning than to physical therapy.

This distinction matters for several reasons. Sports vision training does not require (or typically receive) insurance coverage — it is a premium service that athletes and teams pay for willingly. It does not require the same clinical oversight as medical vision therapy. And its evidence base, while growing, consists largely of smaller studies with heterogeneous methods, making definitive claims about effect sizes difficult.

The most intellectually honest assessment of the current evidence is that sports vision training produces measurable improvements in visual-cognitive test performance, with promising but inconsistent evidence for transfer to actual athletic performance. The gap between laboratory measurement and game-day impact is real but narrowing as study designs improve and training protocols become more sophisticated.

Professional teams appear to have done their own cost-benefit analysis and concluded that the investment is worthwhile. When every marginal advantage matters — and player salaries make even small performance improvements economically significant — the risk-reward math favors vision training even with imperfect evidence.

The Trickle-Down Effect

The market's future growth depends less on professional sports — which will continue expanding investment regardless — than on adoption by three downstream populations.

Youth and college athletics represent the largest volume opportunity. As awareness of sports vision training spreads through coaching education, sports science curricula, and parent networks, demand for youth-accessible programs is growing. College athletic programs, competing for recruiting advantages, are adding vision training to their performance facilities. The case study of a college baseball team achieving conference-leading improvement after adopting vision training circulates through coaching communities as a proof point.

Recreational and amateur athletes are an emerging market segment. Weekend warriors, fitness enthusiasts, and aging athletes seeking to maintain reaction time and visual processing speed represent a large population with disposable income and a demonstrated willingness to invest in performance. The consumer-facing products from companies like Senaptec (strobe goggles retail around $300 to $500) and app-based training platforms are designed to capture this market.

Crossover with clinical vision therapy may prove to be the most interesting opportunity. An optometrist who offers both clinical vision therapy for patients with diagnosed conditions and sports vision training for athletes and performance-seekers can serve a broader market from the same clinical platform. The technology overlaps — NeuroTracker, for example, is used in both concussion rehabilitation and athletic training. Practices that bridge clinical and performance applications may find the most sustainable business model.

The $1 Billion Trajectory

The sports vision training market's path from $500 million to $1.1 billion by 2032 depends on several assumptions: continued professional league investment, VR technology maturation, youth sports adoption, and growing consumer awareness. All four trends are moving in the right direction.

The market also benefits from a dynamic that most healthcare segments lack — it does not depend on insurance coverage. Athletes, teams, and performance-focused consumers pay out of pocket because they perceive direct value. This insulates the market from the payer constraints that limit growth in clinical vision therapy and creates a premium pricing environment that attracts investment and innovation.

For the eye care industry, sports vision training represents both a revenue opportunity and a marketing gateway. The parent who brings their child in for sports vision screening may discover a convergence insufficiency that would otherwise have gone undetected. The concussion-screened athlete may learn about neuro-optometric rehabilitation. Sports vision training is an on-ramp to a broader conversation about visual health — one that happens to come with a billion-dollar market attached.


This is the fourth article in a five-part series examining the vision therapy market. Read the series overview: "The Vision Therapy Market Is Bigger Than Anyone Thinks."